HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nora I Perrone-Bizzozero Selected Research

GAP-43 Protein (GAP 43 Protein)

12/2007Coordinated expression of HuD and GAP-43 in hippocampal dentate granule cells during developmental and adult plasticity.
10/2006Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia.
2/2005Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia.
1/2004Fetal alcohol exposure alters GAP-43 phosphorylation and protein kinase C responses to contextual fear conditioning in the hippocampus of adult rat offspring.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nora I Perrone-Bizzozero Research Topics

Disease

9Schizophrenia (Dementia Praecox)
01/2015 - 02/2005
2Neurodegenerative Diseases (Neurodegenerative Disease)
03/2021 - 01/2021
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
03/2021 - 01/2021
2Fetal Alcohol Spectrum Disorders
04/2016 - 11/2010
1Substance-Related Disorders (Drug Abuse)
09/2021
1Parkinson Disease (Parkinson's Disease)
03/2021
1Dementia (Dementias)
03/2021
1Alzheimer Disease (Alzheimer's Disease)
03/2021
1Neuroinflammatory Diseases
01/2021
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2016
1Demyelinating Diseases (Demyelinating Disease)
11/2016
1Multiple Sclerosis
11/2016
1Binge Drinking
04/2016
1Cardiovascular Diseases (Cardiovascular Disease)
04/2012
1Inflammation (Inflammations)
04/2012
1Obesity
04/2012
1Pathologic Processes
04/2012
1Neurofibromatosis 1 (Neurofibromatosis Type I)
11/2010
1Seizures (Absence Seizure)
12/2007
1Memory Disorders (Memory Loss)
05/2007
1Bipolar Disorder (Manic Depressive Psychosis)
02/2005
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
12/2004
1Cognitive Dysfunction
01/2004

Drug/Important Bio-Agent (IBA)

6Messenger RNA (mRNA)IBA
09/2021 - 10/2006
4MicroRNAs (MicroRNA)IBA
09/2021 - 04/2016
4GAP-43 Protein (GAP 43 Protein)IBA
12/2007 - 01/2004
3Biomarkers (Surrogate Marker)IBA
03/2021 - 11/2010
3gamma-Aminobutyric Acid (GABA)IBA
12/2009 - 10/2006
2RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2021 - 05/2007
2GABA-A Receptors (GABA(A) Receptor)IBA
01/2011 - 12/2009
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2009 - 12/2008
1Circular RNAIBA
09/2021
1Untranslated RNA (Noncoding RNA)IBA
09/2021
1diazonaphthalenedisulfonic acid (NDS)IBA
03/2021
1AntioxidantsIBA
11/2016
1Glutathione (Reduced Glutathione)IBA
11/2016
1Peptides (Polypeptides)IBA
11/2016
1Ethanol (Ethyl Alcohol)IBA
04/2016
1Genetic Markers (Genetic Marker)IBA
01/2015
1Glutamic Acid (Glutamate)FDA Link
05/2014
1Apolipoprotein E4IBA
04/2012
1Calcitonin Gene-Related PeptideIBA
11/2010
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
11/2010
1Indicators and Reagents (Reagents)IBA
11/2010
1Phencyclidine (Angel Dust)IBA
12/2009
1EnzymesIBA
12/2009
1GABA Plasma Membrane Transport ProteinsIBA
12/2009
1Cholinergic ReceptorsIBA
01/2009
1Aromatic-L-Amino-Acid DecarboxylasesIBA
01/2009
1Neurotransmitter Agents (Neurotransmitter)IBA
12/2008
1N-Methylaspartate (NMDA)IBA
12/2008
1metabotropic glutamate receptor 2IBA
12/2008
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
12/2008
1RNA (Ribonucleic Acid)IBA
10/2006
1Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2006
1SynaptophysinIBA
02/2005
1Proteins (Proteins, Gene)FDA Link
02/2005
1Myelin Basic ProteinIBA
12/2004

Therapy/Procedure

1Lenses
11/2010